Go Pro
OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

MusclePharm logo

About MusclePharm Stock (OTCMKTS:MSLP)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$7 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MusclePharm Corp is a developer, manufacturer and distributor of branded sports nutrition and functional nutrition products. The company designs and markets a range of performance supplements intended for athletes, fitness enthusiasts and active consumers seeking support for muscle growth, recovery and overall wellness. Its product lines encompass protein powders, pre-workout formulations, recovery blends and daily nutritional supplements.

Within its sports nutrition category, MusclePharm offers protein powders such as whey, plant-based and casein formulas, along with targeted intra-workout and post-workout recovery blends. The functional nutrition segment includes meal replacements, health-oriented vitamins, adaptogenic compounds and specialty mixes aimed at weight management, joint health and energy support. Many of its offerings feature proprietary delivery systems and ingredient combinations designed to differentiate the brand in a crowded marketplace.

MusclePharm’s products are sold through a broad network of distributors, specialty sports nutrition retailers, e-commerce platforms and gym-based outlets. The company serves customers in North America, Europe, Asia and select emerging markets, leveraging strategic partnerships and co-branding agreements to expand its international footprint. Its go-to-market strategy emphasizes athlete endorsements, influencer collaborations and scientific research partnerships to build brand credibility.

Founded in 2008 by former professional athlete Brad Pyatt, MusclePharm went public in 2010 to fund its growth and product innovation. Pyatt has guided the company’s focus on performance-driven formulations and marketing initiatives that resonate with competitive athletes. Over time, leadership has evolved to include a team of executives with backgrounds in consumer packaged goods, regulatory compliance and global supply chain management, underscoring the company’s commitment to quality, safety and regulatory adherence.

AI Generated. May Contain Errors.

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MSLP Stock News Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
The 5 best muscle rubs of 2024
See More Headlines

MSLP Stock Analysis - Frequently Asked Questions

MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.32. The firm earned $50.48 million during the quarter, compared to the consensus estimate of $55 million.

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF), Humacyte (HUMA) and

Company Calendar

Last Earnings
8/10/2015
Today
9/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MSLP
CIK
1415684
Fax
N/A
Employees
20
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.87 million
Net Margins
-38.51%
Pretax Margin
-38.52%
Return on Equity
N/A
Return on Assets
-169.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$50.04 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
33,390,000
Free Float
13,121,000
Market Cap
$7 thousand
Optionable
Not Optionable
Beta
-0.07

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:MSLP) was last updated on 9/9/2026 by MarketBeat.com Staff.
From Our Partners